Wählen Sie Ihr Land oder Ihre Region

Sie sind jetzt bei Switzerland (Deutsch)
Home / Über uns / Investors / Newsroom / Arjo interim report January-March 2022
The share Arjo B 30 Mai 2024 17:29 4.01 EUR (+0.35%)
❮ Neuigkeiten

Arjo interim report January-March 2022

”Demand for our products and solutions remains very high. The Group grew organically by 1.4%, supported by a strong order intake and an order book for capital equipment which is now significantly higher than at the end of the corresponding period last year. The global challenges within supply chain remain, and the organization continues to manage the situation with sharp focus,” says Joacim Lindoff, President & CEO.

“We have a high activity level that is now approaching the level we saw before the pandemic, and we continue to implement our strategy with full force. A brand new generation of mattresses for preventing pressure injuries was launched during the quarter that, together with the SEM scanner, further strengthens our offering within pressure injury prevention. With continued high demand for capital equipment, service and rental I look forward to another successful 2022 for Arjo,” concludes Joacim Lindoff.

January-March 2022 in brief

  • Net sales increased to SEK 2,370 M (2,168).
    Net sales grew organically by 1.4%.
  • Adjusted EBITDA amounted to SEK 490 M (495).
  • Adjusted operating profit amounted to SEK 237 M (260).
  • Profit after financial items amounted to SEK 218 M (231).
  • Earnings per share amounted to SEK 0.60 (0.64).
  • Cash flow from operations amounted to SEK 25 M (275).
  • Cash conversion was 5.3% (56.5).
  • AtmosAir Velaris was launched during the quarter, a new generation of mattresses for pressure injury prevention.

Telephone conference

Fund managers, analysts and the media are invited to a teleconference on April 22 at 08.00 CEST. Please see details below to join the conference:

Sweden: +46 8 505 583 58      

USA: +1 646 722 4957

UK: +44 333 300 9034


A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q1-2022
Alternatively, use the following link to download the presentation:

A recording of the teleconference will be available for 90 days via the following link: https://tv.streamfabriken.com/arjo-q1-2022

For more information, please contact:


Maria Nilsson, Acting EVP Marketing Communication & Public Relations

Tel: +46 734 244 515

Email: maria.nilsson@arjo.com 


Sara Ehinger, VP Investor Relations & Corporate Communications

Tel: +46 723 597 794

Email: sara.ehinger@arjo.com


This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on April 22, 2022.

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With 6,500 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com


Arjo interim report January-March 2022